Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature-Reference-Cited by-同舟云学术

Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature

Published:2012-11 Issue:11 Volume:48 Page:1085-1089
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Rabinowits Guilherme,Haddad Robert I.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference59 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. The epidermal growth factor family;Carpenter,1991

3. Untangling the ErbB signaling network;Yarden;Nat Rev Mol Cell Biol,2001

4. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer;Grandis;Cancer Res,1993

5. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients;Bei;J Pathol,2004

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab;Cancer Gene Therapy;2024-07-31

2. Nuclear miR-451a activates KDM7A and leads to cetuximab resistance in head and neck squamous cell carcinoma;Cellular and Molecular Life Sciences;2024-06-28

3. Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas;Cells;2024-06-11

4. Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity;Scientific Reports;2023-12-18

5. Fibromodulin overexpression drives oral squamous cell carcinoma via activating downstream EGFR signaling;iScience;2023-11